Martine Daujat-Chavanieu

Dr. Martine Daujat-Chavanieu

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
CDCédric Duret
Cédric Duret
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
MVMarie-José Vilarem
Marie-José Vilarem
PMPatrick Maurel
Patrick Maurel
The expression of many genes involved in xenobiotic/drug metabolism and transport is regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR). These receptors establish crosstalk with other nuclear receptors or transcription factors controlling signaling pathways that regulate the homeostasis of bile acids, lipids, glucose, inflammation, vitamins, hormones, and others. These crosstalks are expected to modify profoundly our vision of xenobiotic/drug disposition and toxicity. They provide molecular mechanisms to explain how physiopathological stimuli affect xenobiotic/drug disposition, and how xenobiotics/drugs may affect physiological functions and generate toxic responses. In addition, the possibility that xenosensors may control other signaling pathways opens the way to new pharmacological opportunities.

1 September 1990 in Gastroenterology
Verified
Journal Article
Closed access
DDDominique Diaz
Dominique Diaz
IFIsabelle Fabrev
Isabelle Fabrev
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
BABernard Saint Aubert
Bernard Saint Aubert
PBPhilippe Bories
Philippe Bories
PMPatrick Maurel
Patrick Maurel

1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
JPJean-Marc Pascussi
Jean-Marc Pascussi
LPLydiane Pichard-Garcia
Lydiane Pichard-Garcia
MVMarie-Jose Vilarem
Marie-Jose Vilarem
PMPatrick Maurel
Patrick Maurel
Although cytochrome P450 2C9 (CYP2C9) is a major CYP expressed in the adult human liver, its mechanism of regulation is poorly known. In previous work, we have shown that CYP2C9is inducible in primary human hepatocytes by xenobiotics including dexamethasone, rifampicin, and phenobarbital. The aim of this work was to investigate the molecular mechanism(s) controlling the inducible expression of CYP2C9. Deletional analysis ofCYP2C9 regulatory region (+21 to −2088) in the presence of various hormone nuclear receptors suggested the presence of two functional response elements, a glucocorticoid receptor-responsive element (−1648/−1684) and a constitutive androstane receptor-responsive element (CAR, −1783/−1856). Each of these were characterized by co-transfection experiments, directed mutagenesis, gel shift assays, and response to specific antagonists RU486 and androstanol. By these experiments we located a glucocorticoid-responsive element imperfect palindrome at −1662/−1676, and a DR4 motif at −1803/−1818 recognized and transactivated by human glucocorticoid receptor and by hCAR and pregnane X receptor, respectively. Identification of these functional elements provides rational mechanistic basis for CYP2C9induction by dexamethasone (submicromolar concentrations), and by phenobarbital and rifampicin, respectively. CYP2C9 appears therefore to be a primary glucocorticoid-responsive gene, which in addition, may be induced by xenobiotics through CAR/pregnane X receptor activation.

1 August 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
LPLydiane Pichard-Garcia
Lydiane Pichard-Garcia
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
JFJean-Michel Fabre
Jean-Michel Fabre
MVMarie-José Vilarem
Marie-José Vilarem

3 September 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
VDVanessa Delfosse
Vanessa Delfosse
BDBéatrice Dendele
Béatrice Dendele
THTiphaine Huet
Tiphaine Huet
MGMarina Grimaldi
Marina Grimaldi
ABAbdelhay Boulahtouf
Abdelhay Boulahtouf
WBWilliam Bourguet
William Bourguet
Humans are chronically exposed to multiple exogenous substances, including environmental pollutants, drugs and dietary components. Many of these compounds are suspected to impact human health, and their combination in complex mixtures could exacerbate their harmful effects. Here we demonstrate that a pharmaceutical oestrogen and a persistent organochlorine pesticide, both exhibiting low efficacy when studied separately, cooperatively bind to the pregnane X receptor, leading to synergistic activation. Biophysical analysis shows that each ligand enhances the binding affinity of the other, so the binary mixture induces a substantial biological response at doses at which each chemical individually is inactive. High-resolution crystal structures reveal the structural basis for the observed cooperativity. Our results suggest that the formation of ‘supramolecular ligands’ within the ligand-binding pocket of nuclear receptors contributes to the synergistic toxic effect of chemical mixtures, which may have broad implications for the fields of endocrine disruption, toxicology and chemical risk assessment.

1 October 2017 in Cell Reports
Verified
Journal Article
Open access
AIAlison Iroz
Alison Iroz
AMAlexandra Montagner
Alexandra Montagner
FBFadila Benhamed
Fadila Benhamed
FLFrançoise Levavasseur
Françoise Levavasseur
APArnaud Polizzi
Arnaud Polizzi
CPCatherine Postic
Catherine Postic
While the physiological benefits of the fibroblast growth factor 21 (FGF21) hepatokine are documented in response to fasting, little information is available on Fgf21 regulation in a glucose-overload context. We report that peroxisome-proliferator-activated receptor α (PPARα), a nuclear receptor of the fasting response, is required with the carbohydrate-sensitive transcription factor carbohydrate-responsive element-binding protein (ChREBP) to balance FGF21 glucose response. Microarray analysis indicated that only a few hepatic genes respond to fasting and glucose similarly to Fgf21. Glucose-challenged Chrebp-/- mice exhibit a marked reduction in FGF21 production, a decrease that was rescued by re-expression of an active ChREBP isoform in the liver of Chrebp-/- mice. Unexpectedly, carbohydrate challenge of hepatic Pparα knockout mice also demonstrated a PPARα-dependent glucose response for Fgf21 that was associated with an increased sucrose preference. This blunted response was due to decreased Fgf21 promoter accessibility and diminished ChREBP binding onto Fgf21 carbohydrate-responsive element (ChoRE) in hepatocytes lacking PPARα. Our study reports that PPARα is required for the ChREBP-induced glucose response of FGF21.